Logo image of BMA

BANCO MACRO SA-ADR (BMA) Stock Fundamental Analysis

NYSE:BMA - New York Stock Exchange, Inc. - US05961W1053 - ADR - Currency: USD

96.24  +0.35 (+0.37%)

After market: 96.24 0 (0%)

Fundamental Rating

4

Taking everything into account, BMA scores 4 out of 10 in our fundamental rating. BMA was compared to 405 industry peers in the Banks industry. BMA may be in some trouble as it scores bad on both profitability and health. BMA is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past 5 years BMA has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: BMA reported negative operating cash flow in multiple years.
BMA Yearly Net Income VS EBIT VS OCF VS FCFBMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500B -500B -1T -1.5T

1.2 Ratios

With an excellent Return On Assets value of 5.16%, BMA belongs to the best of the industry, outperforming 99.75% of the companies in the same industry.
The Return On Equity of BMA (18.93%) is better than 97.49% of its industry peers.
Industry RankSector Rank
ROA 5.16%
ROE 18.93%
ROIC N/A
ROA(3y)4.51%
ROA(5y)4.21%
ROE(3y)16.17%
ROE(5y)16.7%
ROIC(3y)N/A
ROIC(5y)N/A
BMA Yearly ROA, ROE, ROICBMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

BMA has a Profit Margin of 12.84%. This is in the lower half of the industry: BMA underperforms 79.65% of its industry peers.
BMA's Profit Margin has declined in the last couple of years.
BMA does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 12.84%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y5.35%
PM growth 5Y-6.18%
GM growth 3YN/A
GM growth 5YN/A
BMA Yearly Profit, Operating, Gross MarginsBMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for BMA remains at a similar level compared to 1 year ago.
BMA has less shares outstanding than it did 5 years ago.
BMA has a worse debt/assets ratio than last year.
BMA Yearly Shares OutstandingBMA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
BMA Yearly Total Debt VS Total AssetsBMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2T 4T 6T

2.2 Solvency

A Debt/Equity ratio of 0.14 indicates that BMA is not too dependend on debt financing.
BMA has a better Debt to Equity ratio (0.14) than 65.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
BMA Yearly LT Debt VS Equity VS FCFBMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1T -1T 2T

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BMA Yearly Current Assets VS Current LiabilitesBMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200B 400B 600B

More info and screens

9

3. Growth

3.1 Past

BMA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 424.70%, which is quite impressive.
BMA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 101.85% yearly.
The Revenue has grown by 296.55% in the past year. This is a very strong growth!
Measured over the past years, BMA shows a very strong growth in Revenue. The Revenue has been growing by 119.85% on average per year.
EPS 1Y (TTM)424.7%
EPS 3Y168.47%
EPS 5Y101.85%
EPS Q2Q%524.11%
Revenue 1Y (TTM)296.55%
Revenue growth 3Y139.02%
Revenue growth 5Y119.85%
Sales Q2Q%-24.94%

3.2 Future

Based on estimates for the next years, BMA will show a very strong growth in Earnings Per Share. The EPS will grow by 24.22% on average per year.
BMA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 58.43% yearly.
EPS Next Y-30.82%
EPS Next 2Y22.36%
EPS Next 3Y24.22%
EPS Next 5YN/A
Revenue Next Year285.01%
Revenue Next 2Y96.34%
Revenue Next 3Y58.43%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BMA Yearly Revenue VS EstimatesBMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1T 2T 3T 4T
BMA Yearly EPS VS EstimatesBMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5K 10K 15K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
BMA Price Earnings VS Forward Price EarningsBMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BMA Per share dataBMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share

4.3 Compensation for Growth

A more expensive valuation may be justified as BMA's earnings are expected to grow with 24.22% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.36%
EPS Next 3Y24.22%

More info and screens

0

5. Dividend

5.1 Amount

BMA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BANCO MACRO SA-ADR

NYSE:BMA (2/4/2025, 8:04:00 PM)

After market: 96.24 0 (0%)

96.24

+0.35 (+0.37%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)11-22 2024-11-22
Earnings (Next)N/A N/A
Inst Owners5.03%
Inst Owner Change8.76%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.05B
Analysts78.46
Price TargetN/A
Short Float %1.18%
Short Ratio1.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP42.46%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)267.88%
Min EPS beat(2)244.87%
Max EPS beat(2)290.89%
EPS beat(4)2
Avg EPS beat(4)100.29%
Min EPS beat(4)-71.84%
Max EPS beat(4)290.89%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)29.73%
Min Revenue beat(2)-69.39%
Max Revenue beat(2)128.84%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)4.65%
EPS NQ rev (3m)56.15%
EPS NY rev (1m)-34.9%
EPS NY rev (3m)-34.9%
Revenue NQ rev (1m)4.7%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-5.44%
Revenue NY rev (3m)-5.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpSN/A
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.16%
ROE 18.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 12.84%
GM N/A
FCFM N/A
ROA(3y)4.51%
ROA(5y)4.21%
ROE(3y)16.17%
ROE(5y)16.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y5.35%
PM growth 5Y-6.18%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 2.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)3.38%
Cap/Sales(5y)3.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)424.7%
EPS 3Y168.47%
EPS 5Y101.85%
EPS Q2Q%524.11%
EPS Next Y-30.82%
EPS Next 2Y22.36%
EPS Next 3Y24.22%
EPS Next 5YN/A
Revenue 1Y (TTM)296.55%
Revenue growth 3Y139.02%
Revenue growth 5Y119.85%
Sales Q2Q%-24.94%
Revenue Next Year285.01%
Revenue Next 2Y96.34%
Revenue Next 3Y58.43%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14888.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-43593.1%
OCF growth 3YN/A
OCF growth 5YN/A